Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Large And Small-Scale Bioprocessing Market Expected to Grow Between 2025 And 2029?
The market size of both large and small-scale bioprocessing has experienced swift expansion in the past few years. The expected growth is from a size of $59.63 billion in 2024, escalating to $67.85 billion in 2025, with a compound annual growth rate (CAGR) of 13.8%. Factors such as growth in the medical industry, stringent regulatory standards, advancements in technology, expansion of the pharmaceutical and biotech sector, and worries about food safety have sparked the expansion in the historic period.
What Growth Rate Is Anticipated for the Large And Small-Scale Bioprocessing Market in the Coming Years?
There is an anticipation of swift expansion in both the large-scale and small-scale bioprocessing market in the approaching years. The predicted surge to $112.2 billion by 2029 will be at a compound annual growth rate (CAGR) of 13.4%. Factors contributing to this projected growth during the forecast period include rising healthcare costs, growth in the pharmaceutical and biotechnology arenas, technological advancements, regulatory demands, heightened awareness around food safety, and the repercussions of the COVID-19 pandemic. The forecast period will also see trends such as embracing innovative technologies, geographical market expansion, sterilization services being outsourced, commitment to sustainability, adoption of hybrid sterilization techniques, and provision of tailored sterilization solutions.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15845&type=smp
Who Are the Leading Companies in the Large And Small-Scale Bioprocessing Market?
Major companies operating in the large and small-scale bioprocessing market are F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, 3M Company, Takeda Pharmaceutical Company Ltd., Danaher Corporation, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Becton Dickinson and Company (BD), Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company, Lonza Group, Sun Pharmaceutical Industries Ltd., GE Healthcare Life Sciences, Sartorius AG, Dr. Reddy’s Laboratories Ltd., Alkem Laboratories Limited, Piramal Enterprises Ltd
What Are the Key Drivers of the Large And Small-Scale Bioprocessing Market?
The escalating need for biologics is predicted to significantly stimulate the expansion of both large and small-scale bioprocessing markets. Biologics are medicinal products coming from either living organisms or their constituent parts, comprising vaccines, blood and blood components, gene therapies, tissues and recombinant therapeutic proteins. This surge in demand for biologics is propelled by advancements in biotechnology, an increased comprehension of disease mechanisms, and the necessity for personalized and targeted treatments. Both large and small-scale bioprocessing play critical roles in the successful development and commercialization of biologics. Small-scale bioprocessing is crucial for early development stages, optimization, and feasibility studies, while large-scale bioprocessing is cardinal for the efficient, consistent production of biologics, ensuring adherence to regulatory standards for commercial distribution. For example, the National Library of Medicine, a US-based medical library, revealed that in February 2024, the Food and Drug Administration (FDA) approved 55 new drugs, inclusive of 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), representing a 50% rise compared to the 37 approvals in 2023. Consequently, the burgeoning demand for biologics fuels the expansion of the large and small-scale bioprocessing market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=15845&type=smp
What Are the Key Market Segments in the Large And Small-Scale Bioprocessing Industry?
The large and small-scale bioprocessing market covered in this report is segmented –
1) By Product: Bioreactors Or Fermenters, Cell Culture Products, Filtration Assemblies, Bioreactors Accessories, Bags And Containers, Other Products
2) By Mode: In-house, Outsourced
3) By Workflow: Downstream Processing, Fermentation, Upstream Processing
4) By Scale: Industrial Scale, Small Scale
5) By Application: Biopharmaceuticals, Specialty Industrial Chemicals, Environmental Aids
Subsegments:
1) Bioreactors Or Fermenters: Single-Use Bioreactors, Stainless Steel Bioreactors, Glass Bioreactors
2) Cell Culture Products: Cell Culture Media, Sera And Supplements, Reagents
3) Filtration Assemblies: Membrane Filters, Depth Filters, Tangential Flow Filtration Systems
4) Bioreactor Accessories: Spargers, Impellers, Sensors And Probes
5) Bags And Containers: Single-Use Bags, Storage Containers, Transfer Bags
6) Other Products: Mixers, Tubing And Connectors, Sampling Systems
What Are the Latest Trends in the Large And Small-Scale Bioprocessing Market?
Leading businesses within the bioprocessing sector, catering to both large and small-scale markets, are making strides in providing customers with state-of-the-art products like single-use centrifuge systems. These are pre-sterilized, disposable systems created for the purpose of separating biological materials used in bioprocessing. For example, Thermo Fisher Scientific Inc., a prominent US biotechnology firm, introduced its DynaSpin Single-Use Centrifuge system in September 2022. The system has been developed to enhance large-scale cell culture harvesting, simplifying the separation procedure. It also reduces the dependence on numerous depth filtration cartridges, thereby offering benefits such as an increase in product yield, operational efficiency, cost-effectiveness, and sustainable practices within the production of biologics. The DynaSpin system decreases the production costs and assists in sustainability goals by considerably lowering the need for materials and reducing waste, compared to conventional harvest systems.
Access The Full Report Here:
What Are the Key Regional Markets in the Large And Small-Scale Bioprocessing Industry?
North America was the largest region in the large and small-scale bioprocessing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large and small-scale bioprocessing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15845
This Report Delivers Insight On:
1. How big is the large and small-scale bioprocessing market, and how is it changing globally?
2. Who are the major companies in the large and small-scale bioprocessing market, and how are they performing?
3. What are the key opportunities and risks in the large and small-scale bioprocessing market right now?
4. Which products or customer segments are growing the most in the large and small-scale bioprocessing market?
5. What factors are helping or slowing down the growth of the large and small-scale bioprocessing market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model